Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)

CNY 8.73

(-0.8%)

Long Term Debt Summary of Sichuan Goldstone Asia Pharmaceutical Inc.

  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest annual long term debt in 2023 was 2.71 Million CNY , up 949.53% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest quarterly long term debt in 2024 Q2 was 2.11 Million CNY , down 0.0% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported annual long term debt of 258.43 Thousand CNY in 2022, down -66.77% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported annual long term debt of 777.76 Thousand CNY in 2021, up 5219465717350500.0% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported quarterly long term debt of 1.41 Million CNY for 2024 Q3, down 0.0% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported quarterly long term debt of 2.11 Million CNY for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Historical Annual Long Term Debt of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 2.71 Million CNY 949.53%
2022 258.43 Thousand CNY -66.77%
2021 777.76 Thousand CNY 5219465717350500.0%
2020 - CNY -100.0%
2019 1.00 CNY -100.0%
2018 8 Million CNY -46.67%
2017 15 Million CNY 0.0%
2016 - CNY 0.0%
2015 - CNY 0.0%
2014 - CNY 0.0%
2013 - CNY 0.0%
2012 - CNY 0.0%
2011 - CNY 0.0%

Peer Long Term Debt Comparison of Sichuan Goldstone Asia Pharmaceutical Inc.

Name Long Term Debt Long Term Debt Difference
China National Complete Plant Import & Export Corporation Limited 32.49 Million CNY 91.652%